​
​

Compass Therapeutics (CMPX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Compass Therapeutics Revenue Highlights

00

Compass Therapeutics Revenue by Period

Compass Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Compass Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Compass Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$2.84M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30--

Compass Therapeutics generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Compass Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IDYAIDEAYA Biosciences$23.39M-
IVAInventiva$17.50M$15.58M
ANABAnaptysBio$17.16M$30.02M
NAMSNewAmsterdam Pharma Company$14.09M$2.13M
MGTXMeiraGTx$14.02M$10.91M
KRONKronos Bio$6.29M$2.37M
PRTCPureTech Health$3.33M$178.57K
LYRALyra Therapeutics$1.56M$195.00K
FIXXQ32 Bio$1.16M-
KROSKeros Therapeutics$151.00K$37.00K
CGEMCullinan Oncology--
GPCRStructure Therapeutics--
GOSSGossamer Bio-$9.48M
AVTEAerovate Therapeutics--
REPLReplimune Group--
VIGLVigil Neuroscience--
NVCTNuvectis Pharma--
GLUEMonte Rosa Therapeutics-$4.70M
ELVNEnliven Therapeutics--
CMPXCompass Therapeutics--
MLTXMoonLake Immunotherapeutics--
PEPGPepGen--
TYRATyra Biosciences--

CMPX Revenue FAQ

What is Compass Therapeutics’s yearly revenue?

Compass Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. CMPX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Compass Therapeutics’s quarterly revenue?

Compass Therapeutics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.84M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). CMPX's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

What is Compass Therapeutics’s revenue growth rate?

Compass Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.